Search by Drug Name or NDC

    NDC 68788-7711-09 NAPROXEN 375 mg/1 Details

    NAPROXEN 375 mg/1

    NAPROXEN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is NAPROXEN.

    Product Information

    NDC 68788-7711
    Product ID 68788-7711_2be84410-85ba-4cd5-9e39-eac044271541
    Associated GPIs 66100060000310
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name NAPROXEN
    Proprietary Name Suffix n/a
    Non-Proprietary Name NAPROXEN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 375
    Active Ingredient Units mg/1
    Substance Name NAPROXEN
    Labeler Name Preferred Pharmaceuticals, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091416
    Listing Certified Through 2023-12-31

    Package

    NDC 68788-7711-09 (68788771109)

    NDC Package Code 68788-7711-9
    Billing NDC 68788771109
    Package 90 TABLET in 1 BOTTLE, PLASTIC (68788-7711-9)
    Marketing Start Date 2020-06-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ee7dd3c0-2bbf-41a1-a1b9-28f5932f08ba Details

    Revised: 9/2022